Profile
Richard John Meadows is currently the Managing Director at CTI Life Sciences Fund LP, Director at Ontario Bioscience Industry Organization, Director at The Ontario Institute For Regenerative Medicine, and Director at Phost’in SAS. He previously worked as a Director at Enobia Pharma, Inc. and NeurAxon, Inc., and as a Partner at CDP Capital Private Equity and CDP Capital Technology Ventures.
Meadows holds a graduate degree from McGill University and an MBA from the University of Toronto.
Richard John Meadows active positions
| Companies | Position | Start |
|---|---|---|
CTI Life Sciences Fund LP
CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Chief Executive Officer | - |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services Operates membership organization that engages in strategy, programming, policy development and advocacy | Director/Board Member | 12/12/2013 |
The Ontario Institute For Regenerative Medicine
The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Operates as stem cell and regenerative medicine research company | Director/Board Member | - |
Phost’in SAS
Phost’in SAS Pharmaceuticals: MajorHealth Technology Manufactures n-glycosylation therapeutics for cancer treatments | Director/Board Member | 01/04/2020 |
Former positions of Richard John Meadows
| Companies | Position | End |
|---|---|---|
CDP Capital Technology Ventures
CDP Capital Technology Ventures Investment ManagersFinance Venture capital investment firm | Corporate Officer/Principal | - |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Director/Board Member | - |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Director/Board Member | - |
CDP Capital Private Equity
CDP Capital Private Equity Investment ManagersFinance CDPQ invests in ESG companies located in the United States, Europe, Latin America, Canada and Asia-Pacific regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size ranging from CAD 75 - 500 million. It acquires minority stake. | Private Equity Investor | - |
Training of Richard John Meadows
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
CDP Capital Private Equity
CDP Capital Private Equity Investment ManagersFinance CDPQ invests in ESG companies located in the United States, Europe, Latin America, Canada and Asia-Pacific regions. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size ranging from CAD 75 - 500 million. It acquires minority stake. | Finance |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
CTI Life Sciences Fund LP
CTI Life Sciences Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
CDP Capital Technology Ventures
CDP Capital Technology Ventures Investment ManagersFinance Venture capital investment firm | Finance |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services Operates membership organization that engages in strategy, programming, policy development and advocacy | Commercial Services |
The Ontario Institute For Regenerative Medicine
The Ontario Institute For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services Operates as stem cell and regenerative medicine research company | Commercial Services |
Phost’in SAS
Phost’in SAS Pharmaceuticals: MajorHealth Technology Manufactures n-glycosylation therapeutics for cancer treatments | Health Technology |
- Stock Market
- Insiders
- Richard John Meadows
















